Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
305.2 INR | +1.58% | -1.86% | -22.77% |
05-22 | Indoco Remedies Gets Final Nod from US FDA for Pregabalin Capsules | MT |
05-21 | Indoco Remedies Ltd. Receives Final ANDA Approval from USFDA for Pregabalin Capsules | CI |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-22.77% | 332M | |
+42.60% | 739B | |
+32.34% | 598B | |
-5.74% | 353B | |
+17.79% | 318B | |
+3.37% | 285B | |
+16.47% | 240B | |
+9.26% | 210B | |
-5.07% | 206B | |
+6.74% | 164B |
- Stock Market
- Equities
- INDOCO Stock
- News Indoco Remedies Limited
- Transcript : Indoco Remedies Limited, Q1 2023 Earnings Call, Aug 09, 2022